2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate is a pyridyl disulfide-based ADC linker with NHS ester functionality, facilitating stable antibody-payload conjugation and controlled intracellular payload release to enhance ADC specificity and efficacy.
Structure of 107348-47-0
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
2,5-Dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate is a versatile compound with significant potential in biochemical research and industrial applications. Here are some key applications of this compound:
Organic Synthesis: The compound can be used as a reagent in organic synthesis, particularly for the formation of disulfide bonds. It facilitates the introduction of sulfur atoms into molecular frameworks, making it invaluable for constructing sulfur-containing heterocycles. This is crucial for developing novel pharmaceuticals and materials with sulfur functionalities.
Bioconjugation: In the realm of biochemistry, 2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate is employed in bioconjugation reactions where it acts as a linker between biomolecules. It is particularly effective for attaching a wide range of tags or labels to proteins and peptides. This capability is essential for applications in protein tracking, imaging, and therapeutic delivery.
Redox Research: This compound can serve as a redox agent in biochemical experiments aimed at studying oxidative stress and redox regulatory mechanisms. Its disulfide bonds can participate in redox cycling, thus allowing the investigation of cellular responses to oxidative conditions. Understanding these mechanisms helps in developing antioxidant therapies and redox-based diagnostic tools.
Drug Delivery Systems: Researchers can utilize this compound in designing sophisticated drug delivery systems. Its disulfide linkage allows for the creation of redox-responsive carriers that release payloads in environments with specific redox conditions. This targeted release approach enhances the efficacy and reduces the side effects of therapeutics, making it a promising strategy in precision medicine.
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.